NCT00908024: Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors |
|
|
| Terminated | 1/2 | 54 | US, Canada | BMS-754807, cetuximab (Erbitux®), Eributux® | Bristol-Myers Squibb | Colorectal Cancer, Head and Neck Cancer, Neoplasm Metastasis | 12/12 | 12/12 | | |
